Zhenhao Liu, MD
Rheumatology · Sandy, UTNPI 1457771313
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 146 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Amgen at 41.0% of the total. Reporting peaked in 2024 at $1,084 and has fallen 61.5% since, to $418 in 2025.
Across 146 payments — averaging $17.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- UCB, Inc.$533
- AbbVie$467
- Johnson & Johnson$97
- Genentech USA, Inc.$73
- Novartis$67
- plus $263 from 10 others
What the payments were for
- Food & beverage$2,52299%
- Education$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 65 | $1,042 |
| UCB, Inc. | 17 | $533 |
| AbbVie | 31 | $467 |
| Johnson & Johnson | 6 | $97 |
| Genentech USA, Inc. | 4 | $73 |
| Novartis | 4 | $67 |
| GSK | 4 | $60 |
| Pfizer | 4 | $57 |
| Boehringer Ingelheim | 2 | $33 |
| AstraZeneca | 2 | $27 |
| Sobi, Inc | 1 | $19 |
| Radius Health, Inc. | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $14 |
| Mallinckrodt Hospital Products Inc. | 1 | $12 |
| Merck | 1 | $12 |
| Organon | 2 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,542 in reported general payments places this provider in the 65th percentile of 52 rheumatology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 128 | $4,438 |
| MethotrexateMethotrexate Sodium | 76 | $1,722 |
| Leflunomide | 32 | $1,367 |
| Prednisone | 145 | $975 |
| Sulfasalazine | 47 | $948 |
| Alendronate Sodium | 59 | $623 |
| Gabapentin | 42 | $577 |
| Methylprednisolone | 53 | $536 |
| Tramadol Hcl | 46 | $440 |
| Colchicine | 14 | $322 |
| Duloxetine Hcl | 16 | $311 |
| Azathioprine | 12 | $288 |
| Cyclobenzaprine Hcl | 39 | $259 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 26 | $216 |
| Tizanidine Hcl | 29 | $194 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Sandy
- Max LundbergSandy$12
- Catherine BakewellSalt Lake City$1M
- Jessica WalshSlc$162K
- Shruti SanghviVineyard$63K
- Curry KoeningSalt Lake City$59K
- Carmen GotaSt. George$56K
- Seung Yoon LeeMurray$22K
- Matthew CallSpringville$17K
- Wenshu YuProvo$17K
- Michael DarleyProvo$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.